Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for
Read MoreALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for
Read MoreDecember 01, 2023 1 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreDecember 02, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreSopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a
Read MoreDecember 01, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreDecember 01, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MorePfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients
Read MoreThe Biden administration has issued its latest official wish list for Obamacare insurance plans, potentially one of the last major
Read MoreNovember 30, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreFox News officially titled it “The Great Red vs. Blue State Debate.” But the faceoff quickly turned into a full-out
Read More